Eco Serve Pest Supports the 2026 Breakthrough T1D Buffalo Gala
Eco Serve Pest Services was proud to sponsor the 2026 Breakthrough T1D Buffalo Gala, marking the second year our company has taken part in this important community event dedicated to raising awareness and funding research for Type 1 Diabetes (T1D). Held on March 21, 2026, at Rich’s Atrium in Buffalo, New York, the gala brought together local businesses, families, and advocates committed to making a meaningful impact.
As a locally trusted pest control company, Eco Serve Pest believes in supporting organizations that work to improve lives and strengthen our community. Participating in the Breakthrough T1D Gala for the second year reflects our continued commitment to causes that matter to the families and communities we serve. Events like this play a vital role in advancing critical research and moving us closer to a future without type 1 diabetes.
What is the Breakthrough T1D Buffalo Gala?
The Breakthrough T1D Buffalo Gala, presented by West Herr Auto Group, is an annual fundraising event that celebrates progress in Type 1 diabetes research, treatment advancements, and patient support.
Held in the stunning skylit atrium at Rich Products, the event brings together community leaders and supporters for an evening of philanthropy, inspiration, and celebration.
The theme for the 2026 Buffalo Gala is “Breaking Ground,” highlighting the incredible scientific progress being made in the fight against Type 1 diabetes. Funds raised during the event help support innovative research, improved treatments, and expanded access to care for those living with T1D.
Understanding Type 1 Diabetes
Type 1 diabetes (T1D) is a chronic autoimmune disease that affects people of all ages, though it is most commonly diagnosed in children and adolescents.
With T1D, the immune system mistakenly attacks the insulin-producing cells in the pancreas. Insulin is essential because it allows the body to convert food into energy.
Because the body can no longer produce insulin naturally, individuals with Type 1 diabetes must take insulin daily through injections or insulin pumps in order to survive.
Although there is currently no cure, ongoing medical research is producing significant advancements in treatments and technology that improve the quality of life for those living with T1D.
About Breakthrough T1D (Formerly JDRF)
Breakthrough T1D, formerly known as JDRF, is the leading global organization dedicated to Type 1 diabetes research, advocacy, and patient support.
Their mission focuses on:
- Funding innovative T1D research
- Improving daily life for people living with Type 1 diabetes
- Advocating for better healthcare policies and access to care
- Advancing scientific breakthroughs that move us closer to a cure for T1D
By connecting scientists, healthcare providers, policy leaders, and communities, Breakthrough T1D continues to push forward life-changing progress.
Eco Serve Pest’s Commitment to Community
At Eco Serve Pest Services, we believe that being a responsible local business means supporting causes that make our communities healthier and stronger.
Participating in events like the Breakthrough T1D Buffalo Gala allows us to contribute to meaningful change while standing alongside organizations and families who are impacted by Type 1 diabetes.
Community involvement is a core part of who we are, and we are honored to support initiatives that provide hope for families affected by T1D.
This inspiring evening celebrates the progress being made in Type 1 diabetes research and the continued effort needed to achieve a cure.
Supporting the Fight Against Type 1 Diabetes
The Buffalo community has played a powerful role in helping drive progress in Type 1 diabetes research and treatment innovation. Continued support from local organizations, families, and businesses helps fund the breakthroughs that improve lives every day.
Eco Serve Pest Services is proud to stand with Breakthrough T1D in the mission to create a world where Type 1 diabetes is no longer a lifelong condition.
Together, we can help bring us closer to a future without T1D.